Results 1 to 10 of about 10,811 (206)

Remissão de lentigo maligno extenso após tratamento com imiquimod Remission of extensive lentigo maligna after treatment with imiquimod [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2009
Lentigo maligno é um melanoma in situ que mais comumente surge em áreas expostas à radiação ultravioleta, nos pacientes idosos. O tratamento é realizado, principalmente, para minimizar o risco de progressão para lentigo maligno melanoma.
Christiane D. Piazza   +1 more
doaj   +4 more sources

Lipid metabolism dysregulation in solar lentigo: a multi-system-level analysis reveals membrane instability and energy homeostasis disruption [PDF]

open access: yesFrontiers in Cell and Developmental Biology
Solar lentigo is a common hyperpigmented skin condition caused by chronic ultraviolet exposure, primarily affecting photoaged skin. While previous investigations focused on inflammatory and melanogenic mechanisms, the comprehensive role of lipid ...
Sohyun Kim   +12 more
doaj   +2 more sources

Lentigo Maligna [PDF]

open access: yesNew England Journal of Medicine, 2005
Lentigo maligna is a premalignant melanocytic neoplasm occurring on the sun-exposed skin of the middle-aged and elderly. It is believed to represent the in situ phase of lentigo maligna melanoma and, as such, cure is usually the aim of treatment. However, factors such as site and size of lesion and patient co-morbidities may influence the treatment ...
Olivia, Stevenson, Imtiaz, Ahmed
exaly   +4 more sources

Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences

open access: yesActas Dermo-Sifiliográficas, 2022
Topical imiquimod has been used off-label as monotherapy or adjuvant treatment for lentigo maligna. Our aim is to describe treatment modalities, clinical outcomes, and management of recurrence in patients receiving imiquimod for lentigo maligna.Patients ...
I. Poveda-Montoyo   +4 more
doaj   +1 more source

[Artículo traducido] Serie de 14 casos de tratamiento con imiquimod tópico al 5% en lentigo maligno: modalidades terapéuticas y claves para detectar recidivas

open access: yesActas Dermo-Sifiliográficas, 2022
Resumen: Imiquimod tópico ha sido utilizado como monoterapia o tratamiento adyuvante fuera de indicación para el lentigo maligno (LM). Nuestro objetivo es describir las modalidades de tratamiento, los resultados clínicos y el manejo de la recidiva en los
I. Poveda-Montoyo   +4 more
doaj   +1 more source

[Translated article] Update on Lentigo Maligna: Diagnostic Signs and Treatment

open access: yesActas Dermo-Sifiliográficas, 2023
Lentigo maligna is an in situ cutaneous melanoma that arises in sun-damaged skin. Its most common presentation is a progressive, slow-growing, irregularly pigmented spot on the face of older patients. Although the exact percentage of lentigo maligna that
C. Requena, E. Manrique, E. Nagore
doaj   +1 more source

El lentigo maligno: actualización y claves en el diagnóstico y el tratamiento

open access: yesActas Dermo-Sifiliográficas, 2023
Resumen: El lentigo maligno es un melanoma cutáneo in situ que asienta en zonas con daño solar acumulado. Su presentación más habitual es como una mancha irregularmente pigmentada de crecimiento lento y progresivo localizada en la cara de un paciente ...
C. Requena, E. Manrique, E. Nagore
doaj   +1 more source

Spaghetti Technique Versus Wide Local Excision for Lentigo Maligna Affecting the Head and Neck Regions: Surgical Outcome and Descriptive Analysis of 79 Cases From a Single Practice Cohort

open access: yesDermatology Practical & Conceptual, 2023
Introduction: Lentigo maligna is a subtype of melanoma in situ that typically affects the head and neck region with an increasing incidence. Margin-controlled techniques, such as spaghetti technique (ST), have gained popularity over wide local excision (
Manel Martinez-Molina   +8 more
doaj   +1 more source

Synchronous conjunctival melanoma and lentigo maligna melanoma [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
: Lentigo maligna has an extensive and neoplastic character. It typically progresses slowly and may eventually develop into an invasive melanoma, which is called lentigo maligna melanoma. Ocular melanoma is the second most common type of melanoma.
Beatrice Mussio Fornazier Volpini   +4 more
doaj   +1 more source

Lentigo maligna - anatomic location as a potential risk factor for recurrences after non-surgical treatment [PDF]

open access: yes, 2016
Background: A higher incidence of lentigo maligna (LM) recurrences on the nose was previously observed in our cohort after non-surgical treatment. Objectives: To determine histological parameters that might be related to the previously observed higher ...
Doorn, M.B.A. (Martijn) van   +4 more
core   +14 more sources

Home - About - Disclaimer - Privacy